84 related articles for article (PubMed ID: 16752362)
1. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study.
Lundberg J; Halldin C; Farde L
Synapse; 2006 Sep; 60(3):256-63. PubMed ID: 16752362
[TBL] [Abstract][Full Text] [Related]
2. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
Chalon S; Tarkiainen J; Garreau L; Hall H; Emond P; Vercouillie J; Farde L; Dasse P; Varnas K; Besnard JC; Halldin C; Guilloteau D
J Pharmacol Exp Ther; 2003 Jan; 304(1):81-7. PubMed ID: 12490578
[TBL] [Abstract][Full Text] [Related]
4. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods.
Frankle WG; Slifstein M; Gunn RN; Huang Y; Hwang DR; Darr EA; Narendran R; Abi-Dargham A; Laruelle M
J Nucl Med; 2006 May; 47(5):815-26. PubMed ID: 16644752
[TBL] [Abstract][Full Text] [Related]
5. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
Lundberg J; Odano I; Olsson H; Halldin C; Farde L
J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534
[TBL] [Abstract][Full Text] [Related]
6. Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.
Salmi E; Aalto S; Hirvonen J; Långsjö JW; Maksimow AT; Oikonen V; Metsähonkala L; Virkkala J; Någren K; Scheinin H
Neuroimage; 2008 Jun; 41(2):260-9. PubMed ID: 18411060
[TBL] [Abstract][Full Text] [Related]
7. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.
Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L
Synapse; 2005 Dec; 58(3):173-83. PubMed ID: 16138320
[TBL] [Abstract][Full Text] [Related]
8. Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.
Mavel S; Vercouillie J; Garreau L; Raguza T; Ravna AW; Chalon S; Guilloteau D; Emond P
Bioorg Med Chem; 2008 Oct; 16(19):9050-5. PubMed ID: 18793858
[TBL] [Abstract][Full Text] [Related]
9. Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency.
Milak MS; Ogden RT; Vinocur DN; Van Heertum RL; Cooper TB; Mann JJ; Parsey RV
Biol Psychiatry; 2005 Jan; 57(1):102-6. PubMed ID: 15607307
[TBL] [Abstract][Full Text] [Related]
10. A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.
Lundberg J; Borg J; Halldin C; Farde L
Psychopharmacology (Berl); 2007 Dec; 195(3):425-33. PubMed ID: 17874074
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
[TBL] [Abstract][Full Text] [Related]
12. Mapping of serotonin transporters by positron emission tomography with [11C]DASB in conscious common marmosets: comparison with rhesus monkeys.
Yokoyama C; Yamanaka H; Onoe K; Kawasaki A; Nagata H; Shirakami K; Doi H; Onoe H
Synapse; 2010 Aug; 64(8):594-601. PubMed ID: 20340166
[TBL] [Abstract][Full Text] [Related]
13. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
Kim JS; Ichise M; Sangare J; Innis RB
J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
[TBL] [Abstract][Full Text] [Related]
14. Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo.
Marner L; Gillings N; Comley RA; Baaré WF; Rabiner EA; Wilson AA; Houle S; Hasselbalch SG; Svarer C; Gunn RN; Laruelle M; Knudsen GM
J Nucl Med; 2009 Jun; 50(6):900-8. PubMed ID: 19470850
[TBL] [Abstract][Full Text] [Related]
15. Effects of estrogen and testosterone treatment on serotonin transporter binding in the brain of surgically postmenopausal women--a PET study.
Jovanovic H; Kocoska-Maras L; Rådestad AF; Halldin C; Borg J; Hirschberg AL; Nordström AL
Neuroimage; 2015 Feb; 106():47-54. PubMed ID: 25462800
[TBL] [Abstract][Full Text] [Related]
16. Test-Retest Reliability of the SERT Imaging Agent
Adhikarla V; Dunlop BW; Jarkas N; Goodman MM; Mayberg H; Owens MJ; Nye JA
J Nucl Med; 2018 Feb; 59(2):315-319. PubMed ID: 28935840
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.
Jovanovic H; Lundberg J; Karlsson P; Cerin A; Saijo T; Varrone A; Halldin C; Nordström AL
Neuroimage; 2008 Feb; 39(3):1408-19. PubMed ID: 18036835
[TBL] [Abstract][Full Text] [Related]
18. 5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects.
Stenkrona P; Halldin C; Lundberg J
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1190-8. PubMed ID: 23428337
[TBL] [Abstract][Full Text] [Related]
19. An improved synthesis of 4-[18F]-ADAM, a potent serotonin transporter imaging agent.
Huang YY; Huang WS; Chu TC; Shiue CY
Appl Radiat Isot; 2009 Jun; 67(6):1063-7. PubMed ID: 19339192
[TBL] [Abstract][Full Text] [Related]
20. Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography data.
Fazio P; Schain M; Varnäs K; Halldin C; Farde L; Varrone A
Neuroimage; 2016 Jun; 133():313-320. PubMed ID: 26994829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
